![Dario Eklund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dario Eklund
Algemeen Directeur bij
SANTHERA PHARMACEUTICALS HOLDING AG
Vermogen: 2 M $ op 31-05-2026
Profiel
Dario Eklund is currently the Chief Executive Officer at Santhera Pharmaceuticals Holding AG since 2019.
Formerly, the roles included Commercial Director at Novartis AG from 1994 to 2002, General Manager-Switzerland at Sanofi from 2002 to 2004, VP-Business Development & Gintuit Business Unit at Organogenesis, Inc. from 2004 to 2014, Head-Global Business Operations at Vifor Pharma Management AG from 2014 to 2019, Chief Commercial Officer at Corden Pharma Fribourg SA from 2017 to 2019, Member-Supervisory Board at Vifor Fresenius Medical Care Renal Pharma Ltd. from 2017 to 2019, and General Manager-Switzerland Region at Aventis Pharma AG.
Education includes graduate studies at Hanken Svenska Handelshögskolan.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2024 | 110.526 ( 0,74% ) | 2 M $ | 31-05-2026 |
Actieve functies van Dario Eklund
| Bedrijven | Functie | Begin |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Algemeen Directeur | 01-12-2019 |
Eerdere bekende functies van Dario Eklund
| Bedrijven | Functie | Einde |
|---|---|---|
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Corporate Officer/Principal | 30-09-2019 |
| VIFOR PHARMA | Corporate Officer/Principal | 30-09-2019 |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Directeur/Bestuurslid | 01-01-2019 |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Corporate Officer/Principal | 01-01-2014 |
| SANOFI | Corporate Officer/Principal | 01-01-2004 |
Opleiding van Dario Eklund
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Aventis Pharma AG | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
Hanken Svenska Handelshögskolan
 Hanken Svenska Handelshögskolan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Health Technology |
